{
    "id": "0020",
    "question": "A 77-year-old woman presents to the emergency room with the complaints of fever, malaise, and night sweats. She recently observed an enlargement of her axillary lymph nodes, which she examines on a weekly basis. She has a remote history of breast cancer in her 60s that was treated with radiation and chemotherapy. She also reports a history of extensive travel to Africa and a 30-pack-year history of smoking. On physical exam, several axillary lymph nodes are palpable with a large non-tender palpable mass in her right axilla measuring 10 x 8 cm. Fine-needle aspiration demonstrates what the pathologist describes as \"a centroblastic and immunoblastic cell presence, suspicious for non-Hodgkin\u2019s lymphoma (NHL)\u2013diffuse large B cell variant\". Which of the following risk factors is responsible for this patient\u2019s condition?",
    "options": {
        "A": "Travel to Africa",
        "B": "Axillary lymph node involvement",
        "C": "Previous radiation therapy",
        "D": "Previous breast cancer"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"To determine the correct answer, let's evaluate each option in relation to the patient's condition and history. The patient presents with symptoms of fever, malaise, and night sweats, along with a large non-tender palpable mass in her right axilla, which is suggestive of a lymphoma. The fine-needle aspiration results confirm the presence of centroblastic and immunoblastic cells, consistent with a diagnosis of non-Hodgkin's lymphoma (NHL) - diffuse large B cell variant. Option A, travel to Africa, may increase the risk of certain infections that can lead to lymphoma, but it is not a direct risk factor for NHL-diffuse large B cell variant. Option B, axillary lymph node involvement, is a common presentation of lymphoma, but it is not a risk factor that causes the development of NHL. Option C, previous radiation therapy, is a known risk factor for secondary lymphomas, particularly Burkitt lymphoma, but it is not the most likely risk factor for NHL-diffuse large B cell variant. Option D, previous breast cancer, is a known risk factor for secondary NHL, particularly the immunoblastic lymphoma subtype, which is a variant of NHL-diffuse large B cell variant. This is because the treatment of breast cancer with radiation and chemotherapy can increase the risk of developing secondary lymphomas, especially in the field of the previous radiation. Therefore, based on the patient's history and presentation, the most likely risk factor for her condition is her previous breast cancer.\"} \"answer_choice\": \"D\"",
    "snippets": [],
    "scores": [],
    "execution_time": 9.144011974334717
}